Track topics on Twitter Track topics that are important to you
Although the results look very promising, there are still concerns similar to those seen with Sanofi’s Dengvaxia.
Original Article: Takeda’s Dengue Vaccine is Promising, but Safety Issues Still LingerNEXT ARTICLE
Sanofi-Aventis is a global pharmaceutical company with annual sales of $40,871m, placing it the second highest in the world. Although Sanofi-Aventis products are for a a very wide range of health problems, their major products are those for diabetes, o...